• 1
    Unwin N, Setel P, Rashid S, Mugusi F, Mbanya JC, Kitange H, Hayes L, Edwards R, Aspray T, Alberti KG. Noncommunicable diseases in sub-Saharan Africa: where do they feature in the health research agenda? Bull World Health Organ 2001; 79: 94753.
  • 2
    Mensah GA. A heart-healthy and “stroke-free” world through policy development, systems change, and environmental supports: a 2020 vision for sub-Saharan Africa. Ethn Dis 2003; 13( 2 Suppl 2): S4S12.
  • 3
    Parkin DM, Wabinga H, Nambooze S. Completeness in an African cancer registry. Cancer Causes Control 2001; 12: 14752.
  • 4
    Bah E, Parkin DM, Hall AJ, Jack AD, Whittle H. Cancer in the Gambia: 1988–97. Br J Cancer 2001; 84: 120714.
  • 5
    Coleman MP, Bieber CA. CANREG: cancer registration software for microcomputers. IARC Sci Publ 1991; 26774.
  • 6
    Doll R, Smith PG. Cancer incidence in five continents, Vol. IV. Lyon: International Agency for Research on Cancer, 1982.
  • 7
    Boyle P, Parkin DM. Methodes statistiques pour les registres. In: Enregistrement des Cancers Principes et Methods, pp 135172, Lyon: International Agency for Research on Cancer, 1996.
  • 8
    Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001; 2: 53343.
  • 9
    Amir H, Kitinya JN, Parkin DM. A comparative study of carcinoma of the breast in an African population. East Afr Med J 1994; 71: 21518.
  • 10
    Anyanwu SN. Breast cancer in eastern Nigeria: a ten year review. West Afr J Med 2000; 19: 1205.
  • 11
    Ikpatt OF, Kuopio T, Ndoma-Egba R, Collan Y. Breast cancer in Nigeria and Finland: epidemiological, clinical and histological comparison. Anticancer Res 2002; 22: 300512.
  • 12
    Muguti GI. Experience with breast cancer in Zimbabwe. J R Coll Surg Edinb 1993; 38: 758.
  • 13
    Muthuphei MN. Carcinoma of the breast at Ga-Rankuwa Hospital histopathology laboratory (South Africa). Cent Afr J Med 1994; 40: 2547.
  • 14
    Hennis AJ, Hambleton IR, Wu SY, Leske MC, Nemesure B. Breast cancer incidence and mortality in a Caribbean population: comparisons with African-Americans. Int J Cancer 2009; 124: 42933.
  • 15
    Nemesure B, Wu SY, Hambleton IR, Leske MC, Hennis AJ. Risk factors for breast cancer in a black population—the Barbados National Cancer Study. Int J Cancer 2009; 124: 1749.
  • 16
    Bowen RL, Duffy SW, Ryan DA, Hart IR, Jones JL. Early onset of breast cancer in a group of British black women. Br J Cancer 2008; 98: 27781.
  • 17
    Newman LA. Breast cancer in African-American women. Oncologist 2005; 10: 114.
  • 18
    Fregene A, Newman LA. Breast cancer in sub-Saharan Africa: how does it relate to breast cancer in African-American women? Cancer 2005; 103: 154050.
  • 19
    Newman LA. Breast carcinoma in African-American and White women: application of molecular biology to understand outcome disparities. Cancer 2004; 101: 12613.
  • 20
    Chu KC, Anderson WF, Fritz A, Ries LA, Brawley OW. Frequency distributions of breast cancer characteristics classified by estrogen receptor and progesterone receptor status for eight racial/ethnic groups. Cancer 2001; 92: 3745.
  • 21
    Ijaduola TG, Smith EB. Pattern of breast cancer among white-American, African-American, and nonimmigrant west-African women. J Natl Med Assoc 1998; 90: 54751.
  • 22
    Mbonde MP, Amir H, Schwartz-Albiez R, Akslen LA, Kitinya JN. Expression of estrogen and progesterone receptors in carcinomas of the female breast in Tanzania. Oncol Rep 2000; 7: 27783.
  • 23
    Ikpatt OF, Ndoma-Egba R. Oestrogen and progesterone receptors in Nigerian breast cancer: relationship to tumour histopathology and survival of patients. Cent Afr J Med 2003; 49: 1226.
  • 24
    Bird PA, Hill AG, Houssami N. Poor hormone receptor expression in East African breast cancer: evidence of a biologically different disease? Ann Surg Oncol 2008; 15: 19838.
  • 25
    Eniu A, Carlson RW, Aziz Z, Bines J, Hortobagyi GN, Bese NS, Love RR, Vikram B, Kurkure A, Anderson BO. Breast cancer in limited-resource countries: treatment and allocation of resources. Breast J 2006; 12 ( Suppl 1): S38S53.
  • 26
    Brown SB, Mallon EA, Edwards J, Campbell FM, McGlynn LM, Elsberger B, Cooke TG. Is the biology of breast cancer changing? A study of hormone receptor status 1984–1986 and 1996–1997. Br J Cancer 2009; 100: 80710.
  • 27
    Lord SJ, Bernstein L, Johnson KA, Malone KE, McDonald JA, Marchbanks PA, Simon MS, Strom BL, Press MF, Folger SG, Burkman RT, Deapen D, et al. Breast cancer risk and hormone receptor status in older women by parity, age of first birth, and breastfeeding: a case-control study. Cancer Epidemiol Biomarkers Prev 2008; 17: 172330.
  • 28
    Lambe M, Hsieh C, Trichopoulos D, Ekbom A, Pavia M, Adami HO. Transient increase in the risk of breast cancer after giving birth. N Engl J Med 1994; 331: 59.
  • 29
    Liu Q, Wuu J, Lambe M, Hsieh SF, Ekbom A, Hsieh CC. Transient increase in breast cancer risk after giving birth: postpartum period with the highest risk (Sweden). Cancer Causes Control 2002; 13: 299305.
  • 30
    Palmer JR, Wise LA, Horton NJ, ms-Campbell LL, Rosenberg L. Dual effect of parity on breast cancer risk in African-American women. J Natl Cancer Inst 2003; 95: 47883.
  • 31
    Ma H, Bernstein L, Pike MC, Ursin G. Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies. Breast Cancer Res 2006; 8: R43.
  • 32
    Ursin G, Bernstein L, Lord SJ, Karim R, Deapen D, Press MF, Daling JR, Norman SA, Liff JM, Marchbanks PA, Folger SG, Simon MS, et al. Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology. Br J Cancer 2005; 93: 36471.
  • 33
    Wall SR, Scherf CF, Morison L, Hart KW, West B, Ekpo G, Fiander AN, Man S, Gelder CM, Walraven G, Borysiewicz LK. Cervical human papillomavirus infection and squamous intraepithelial lesions in rural Gambia, West Africa: viral sequence analysis and epidemiology. Br J Cancer 2005; 93: 106876.
  • 34
    Kirk GD, Turner PC, Gong Y, Lesi OA, Mendy M, Goedert JJ, Hall AJ, Whittle H, Hainaut P, Montesano R, Wild CP. Hepatocellular carcinoma and polymorphisms in carcinogen-metabolizing and DNA repair enzymes in a population with aflatoxin exposure and hepatitis B virus endemicity. Cancer Epidemiol Biomarkers Prev 2005; 14: 3739.
  • 35
    Allsopp CE, Harding RM, Taylor C, Bunce M, Kwiatkowski D, Anstey N, Brewster D, McMichael AJ, Greenwood BM, Hill AV. Interethnic genetic differentiation in Africa: HLA class I antigens in the Gambia. Am J Hum Genet 1992; 50: 41121.
  • 36
    Jallow M, Teo YY, Small KS, Rockett KA, Deloukas P, Clark TG, Kivinen K, Bojang KA, Conway DJ, Pinder M, Sirugo G, Sisay-Joof F, et al. Genome-wide and fine-resolution association analysis of malaria in West Africa. Nat Genet 2009, May 24 (Epub ahead of print).
  • 37
    Shaw M, van der SM, West B, Paine K, Ceesay S, Bailey R, Walraven G, Morison L, McAdam K. Prevalence of herpes simplex type 2 and syphilis serology among young adults in a rural Gambian community. Sex Transm Infect 2001; 77: 35865.
  • 38
    Walraven G, Scherf C, West B, Ekpo G, Paine K, Coleman R, Bailey R, Morison L. The burden of reproductive-organ disease in rural women in the Gambia, West Africa. Lancet 2001; 357: 11617.